Searched for
ASTRAZENECA DRUG STUDY
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- AstraZeneca's asthma drug fails 'smoker's lung' studyAstraZeneca's Fasenra failed to reduce flare-ups in COPD patients in a late-stage trial, a setback for the company's efforts to address the...
- AstraZeneca drug lowers high blood pressure in late-stage studyAstraZeneca's baxdrostat demonstrated significant blood pressure reduction in a late-stage trial for treatment-resistant hypertension, boos...
- USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZenecaEvusheld is the first long-acting antibody to receive emergency use authorisation in the US for pre-exposure prophylaxis of COVID-19, in ad...
- AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19"An early intervention with our antibody can give a significant reduction in progression to severe disease, with continued protection for m...
- AstraZeneca hits snag in Covid drug developmentThe drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...
- AstraZeneca says antibody treatment failed in preventing COVID-19 in exposed patientsThe company said the participants in the trial were unvaccinated adults older than 18 years with confirmed exposure to a person with the co...
- EU agency says people should get second dose of AstraZeneca tooThe agency said there were "no or limited data to change current recommendations." It said it wasn't known whether the risk of a rare blood...
- UK agency: Under-30s to be offered non-AstraZeneca vaccineThe decision was announced soon after the European Union's drug regulator said it had found a ``possible link'' between the AstraZeneca cor...
- Covid vaccine: Why is AstraZeneca making so many unforced errors?The has been communication of scientific results. November data from trials in the U.K. and Brazil generated confusion over efficacy. This ...
- AstraZeneca says US trial data shows vaccine 79% effectiveThe U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots. The results were announed...
- AstraZeneca inks pact with Research Society for Study of Diabetes in IndiaAs a key facet of this association, the company has unveiled a three-year patient awareness programme, 'Beyond Sugar', developed to benefit...
- AstraZeneca trials only after review by UK’s Drug and Safety Monitoring Board: Serum InstituteThe decision to put the trials on hold was taken by the members of the DSMB after they were informed about the serious adverse events repor...
- India trials of COVID-19 vaccine is going on: Serum InstituteLast month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical t...
- Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UKThe drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and pr...
- AstraZeneca's heart pill safe to use in ambulance but comes with no extra benefitBlood-thinning drug Brilinta by AstraZeneca is safe to use in ambulance but giving it early in provides no extra benefit.
- Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
- Cognizant inks multi-year agreement with AstraZenecaCognizant has inked a deal with AstraZeneca to deliver comprehensive biostatistics and medical reporting services for generating clinical s...
Load More
